Dr. Helder Santos' research interests include the development of nanoparticles/nanomedicines for biomedical and healthcare applications. His current work makes the bridge between engineering, pharmaceutical and medical research. His main research focus is in the use of biodegradable and biocompatible nanoporous silicon nanomaterials, polymers, the application of microfluidics technology for nanoparticle production for simultaneous controlled drug delivery, diagnostic and treatment of cancer, diabetes, and cardiovascular diseases, and further translation of these nanotechnologies into the clinic. Dr. Santos' is author of more than 170 publications in prestigious, high impact, peer-reviewed publications, such as Advanced Materials, ACS Nano, Advanced Functional Materials, Chemistry of Materials, Biomaterials, Small, etc. He has given over 100 invited and keynote lectures at prestigious conferences, universities and summer schools around the world. Dr. Santos is also an Editorial Board Member for several international peer-reviewed journals, Editor and founder of the Mesoporous Biomaterials journal, Academic Editor of PLOS ONE, BioMed Research International, and Journal of Healthcare Engineering, as well as author of the book "Porous Silicon for Biomedical Applications". Moreover, he has received a number of prestigious awards and grants, such as the "Talent Prize in Science" attributed by the Portuguese government in 2013, the European Research Council Starting Grant grantee in 2013, the Young Researcher Award in 2013 and honour distinction for the exceptional scientific productivity in 2014, both attributed by the Faculty of Pharmacy at the University of Helsinki, and the Academy of Finland 2016 Award for Social Impact.